When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ADMA - FDA accepts ADMA Bio's refiled marketing application for RI-002 action date April 2 2019
ADMA Biologics Inc
The FDA has accepted for review ADMA Biologics' (NASDAQ:ADMA) resubmitted BLA seeking approval for lead candidate RI-002 for the treatment of patients with primary immune deficiency disease (PIDD). It received a CRL in July 2016 in response to its original filing.
More news on: ADMA Biologics Inc, Healthcare stocks news,